Medicare Enrolled

Dr. Obeidurahman Rehmani, M.D.

Neurology · Plano, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1600 COIT RD STE 208, Plano, TX 75075
9038935141
Registered in NPPES since 2011
NPI: 1619275963 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rehmani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rehmani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rehmani

Dr. Obeidurahman Rehmani is a neurology specialist in Plano, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Rehmani performed 429 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Rehmani received a total of $11,195 from 54 pharmaceutical and/or device companies across 517 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rehmani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration ▲ 429 Medicare services $11,195 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
429
Medicare services
Bottom 45% in TX for neurology
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
113 $79 $181
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
70 $121 $255
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
61 $56 $129
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
45 $59 $107
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
42 $129 $263
New patient office visit, complex (60-74 min) 34 $144 $312
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
26 $39 $82
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
15 $24 $46
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
12 $90 $193
Video EEG monitoring, 61-84 hours
This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) while simultaneously recording video for a duration of 61 to 84 hours. A healthcare professional reviews the data and provides a report.
11 $232 $455
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,195
Total received (2018-2024)
Avg $1,599/year across 7 years
Top 26% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
517
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,724
2023
$1,127
2022
$1,587
2021
$1,239
2020
$1,681
2019
$1,390
2018
$2,448

Payments by company (2024)

UCB, Inc.
$282
Genentech USA, Inc.
$178
Eisai Inc.
$149
SK Life Science, Inc.
$143
PFIZER INC.
$79
Alexion Pharmaceuticals, Inc.
$79
E.R. Squibb & Sons, L.L.C.
$79
Novartis Pharmaceuticals Corporation
$75
ARGENX US, INC.
$65
ABBVIE INC.
$58
Lundbeck LLC
$57
Kyowa Kirin, Inc.
$54
Neurocrine Biosciences, Inc.
$53
Marinus Pharmaceuticals, Inc.
$50
Biogen, Inc.
$45
Celgene Corporation
$44
JAZZ PHARMACEUTICALS INC.
$37
CATALYST PHARMACEUTICALS, INC.
$28
EMD Serono, Inc.
$25
AstraZeneca Pharmaceuticals LP
$23
BIOTRONIK NRO, Inc.
$23
Amneal Pharmaceuticals LLC
$22
Lilly USA, LLC
$22
Aucta Pharmaceuticals, Inc.
$20
ACADIA Pharmaceuticals Inc
$19
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 35.3% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,636
LivaNova USA, Inc.
$1,517
Eisai Inc.
$616
Avanir Pharmaceuticals, Inc.
$589
Supernus Pharmaceuticals, Inc.
$579
Lilly USA, LLC
$456
Celgene Corporation
$412
Amgen Inc.
$404
ABBVIE INC.
$383
Genentech USA, Inc.
$315
ACADIA Pharmaceuticals Inc
$308
PFIZER INC.
$304
Neurelis, Inc.
$274
Biogen, Inc.
$267
Novartis Pharmaceuticals Corporation
$257
E.R. Squibb & Sons, L.L.C.
$218
SK Life Science, Inc.
$193
GENZYME CORPORATION
$189
Allergan, Inc.
$180
EISAI INC.
$177
Lundbeck LLC
$161
Amneal Pharmaceuticals LLC
$152
Allergan Inc.
$145
Biohaven Pharmaceutical Holding Company Ltd.
$138
Kyowa Kirin, Inc.
$99
Mallinckrodt LLC
$90
Janssen Pharmaceuticals, Inc
$82
CSL Behring
$81
Alexion Pharmaceuticals, Inc.
$79
Teva Pharmaceuticals USA, Inc.
$79
EMD Serono, Inc.
$68
ARGENX US, INC.
$65
AstraZeneca Pharmaceuticals LP
$61
Neurocrine Biosciences, Inc.
$53
Grifols USA, LLC
$51
Marinus Pharmaceuticals, Inc.
$50
Alnylam Pharmaceuticals Inc.
$48
Adamas Pharmaceuticals, Inc.
$44
Biohaven Pharmaceuticals, Inc.
$37
JAZZ PHARMACEUTICALS INC.
$37
AbbVie Inc.
$36
Merz Pharmaceuticals, LLC
$30
Mallinckrodt Hospital Products Inc.
$29
Greenwich Biosciences, Inc.
$29
CATALYST PHARMACEUTICALS, INC.
$28
BIOTRONIK NRO, Inc.
$23
Aucta Pharmaceuticals, Inc.
$20
HOSPIRA, INC.
$20
IMPEL PHARMACEUTICALS INC.
$18
PORTOLA PHARMACEUTICALS, INC.
$17
Acorda Therapeutics, Inc
$16
Sumitomo Pharma America, Inc.
$14
Impax Laboratories, Inc.
$13
Mallinckrodt Enterprises LLC
$11
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · Aimovig · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · Briviact · COMIRNATY · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LYRICA · Leqembi · MAVENCLAD · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · Ocrevus · PANZYGA · Ponvory · Prospera · QULIPTA · REYVOW · RYTARY · SKYCLARYS · SPINRAZA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · Xeomin · ZEPOSIA · ZTALMY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Plano?
Compare neurologists in the Plano area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
225
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY PLANO
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rehmani is a clinical cardiology specialist, with moderate Medicare volume, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rehmani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rehmani performed 113 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rehmani receive payments from pharmaceutical companies?
Yes. Dr. Rehmani received a total of $11,195 from 54 companies across 517 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rehmani's costs compare to other neurologists in Plano?
Dr. Rehmani's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rehmani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →